Genfit
GNFT
GNFT was delisted on the 19th of November, 2025.
18 hedge funds and large institutions have $42.3M invested in Genfit in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 8 closing their positions.
3.66% less ownership
Funds ownership: 9.93% → 6.27% (-3.7%)
25% less funds holding
Funds holding: 24 → 18 (-6)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
44% less capital invested
Capital invested by funds: $76.1M → $42.3M (-$33.8M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$2.46M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$392K |
| 3 |
Jane Street
New York
|
+$248K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$149K |
| 5 |
Morgan Stanley
New York
|
+$53.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$22.2M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.73M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$791K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$787K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$699K |
GNFT Hedge Fund Activity: Q3 2019 in Review
18 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Genfit (GNFT) for Q3 2019, worth a combined $42.3M — down 44% from $76.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GNFT and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Victory Capital Management, adding an estimated $2.46M. The largest seller was OrbiMed, exiting entirely with an estimated $22.2M sold.
- 18 institutional investors held Genfit (GNFT) as of Q3 2019, down from 24 in Q2 2019.
- Funds reported $42.3M of Genfit stock for Q3 2019, down 44% quarter-over-quarter.
- 2 funds opened new Genfit positions in Q3 2019 and 8 closed out, a net change of -6 holders.
- The largest Genfit buyer in Q3 2019 was Victory Capital Management, an estimated $2.46M added.
- The largest Genfit seller in Q3 2019 was OrbiMed, an estimated $22.2M sold.
Based on aggregated 13F filings for Q3 2019.